![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CCNB1 |
Gene summary for CCNB1 |
![]() |
Gene information | Species | Human | Gene symbol | CCNB1 | Gene ID | 891 |
Gene name | cyclin B1 | |
Gene Alias | CCNB | |
Cytomap | 5q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P14635 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
891 | CCNB1 | LZE2T | Human | Esophagus | ESCC | 2.32e-07 | 1.83e+00 | 0.082 |
891 | CCNB1 | LZE24T | Human | Esophagus | ESCC | 2.60e-07 | 4.61e-01 | 0.0596 |
891 | CCNB1 | LZE6T | Human | Esophagus | ESCC | 1.81e-10 | 5.92e-01 | 0.0845 |
891 | CCNB1 | P2T-E | Human | Esophagus | ESCC | 6.27e-26 | 1.41e+00 | 0.1177 |
891 | CCNB1 | P4T-E | Human | Esophagus | ESCC | 5.96e-25 | 1.14e+00 | 0.1323 |
891 | CCNB1 | P5T-E | Human | Esophagus | ESCC | 3.71e-18 | 7.94e-01 | 0.1327 |
891 | CCNB1 | P8T-E | Human | Esophagus | ESCC | 1.72e-05 | 3.14e-01 | 0.0889 |
891 | CCNB1 | P9T-E | Human | Esophagus | ESCC | 3.61e-12 | 8.60e-01 | 0.1131 |
891 | CCNB1 | P10T-E | Human | Esophagus | ESCC | 2.38e-08 | 6.38e-01 | 0.116 |
891 | CCNB1 | P11T-E | Human | Esophagus | ESCC | 2.49e-04 | 7.35e-01 | 0.1426 |
891 | CCNB1 | P12T-E | Human | Esophagus | ESCC | 1.88e-05 | 3.79e-01 | 0.1122 |
891 | CCNB1 | P15T-E | Human | Esophagus | ESCC | 4.63e-09 | 7.82e-01 | 0.1149 |
891 | CCNB1 | P16T-E | Human | Esophagus | ESCC | 2.75e-07 | 3.43e-01 | 0.1153 |
891 | CCNB1 | P17T-E | Human | Esophagus | ESCC | 3.33e-09 | 1.25e+00 | 0.1278 |
891 | CCNB1 | P19T-E | Human | Esophagus | ESCC | 1.07e-06 | 1.54e+00 | 0.1662 |
891 | CCNB1 | P20T-E | Human | Esophagus | ESCC | 2.13e-08 | 6.87e-01 | 0.1124 |
891 | CCNB1 | P21T-E | Human | Esophagus | ESCC | 3.70e-18 | 1.32e+00 | 0.1617 |
891 | CCNB1 | P22T-E | Human | Esophagus | ESCC | 4.14e-13 | 7.51e-01 | 0.1236 |
891 | CCNB1 | P23T-E | Human | Esophagus | ESCC | 2.88e-04 | 6.08e-01 | 0.108 |
891 | CCNB1 | P24T-E | Human | Esophagus | ESCC | 4.71e-16 | 1.06e+00 | 0.1287 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001810519 | Thyroid | ATC | peptidyl-serine phosphorylation | 153/6293 | 315/18723 | 2.28e-08 | 4.42e-07 | 153 |
GO:004578614 | Thyroid | ATC | negative regulation of cell cycle | 181/6293 | 385/18723 | 2.64e-08 | 5.07e-07 | 181 |
GO:200125111 | Thyroid | ATC | negative regulation of chromosome organization | 54/6293 | 86/18723 | 2.84e-08 | 5.41e-07 | 54 |
GO:001820917 | Thyroid | ATC | peptidyl-serine modification | 161/6293 | 338/18723 | 5.23e-08 | 9.44e-07 | 161 |
GO:003367427 | Thyroid | ATC | positive regulation of kinase activity | 212/6293 | 467/18723 | 5.89e-08 | 1.05e-06 | 212 |
GO:007145325 | Thyroid | ATC | cellular response to oxygen levels | 94/6293 | 177/18723 | 6.62e-08 | 1.17e-06 | 94 |
GO:005178311 | Thyroid | ATC | regulation of nuclear division | 77/6293 | 139/18723 | 1.01e-07 | 1.70e-06 | 77 |
GO:190199115 | Thyroid | ATC | negative regulation of mitotic cell cycle phase transition | 94/6293 | 179/18723 | 1.33e-07 | 2.19e-06 | 94 |
GO:004583911 | Thyroid | ATC | negative regulation of mitotic nuclear division | 34/6293 | 48/18723 | 1.49e-07 | 2.41e-06 | 34 |
GO:004593015 | Thyroid | ATC | negative regulation of mitotic cell cycle | 117/6293 | 235/18723 | 1.93e-07 | 3.05e-06 | 117 |
GO:0045931110 | Thyroid | ATC | positive regulation of mitotic cell cycle | 68/6293 | 121/18723 | 2.66e-07 | 4.08e-06 | 68 |
GO:004814532 | Thyroid | ATC | regulation of fibroblast proliferation | 49/6293 | 80/18723 | 3.73e-07 | 5.48e-06 | 49 |
GO:003629425 | Thyroid | ATC | cellular response to decreased oxygen levels | 85/6293 | 161/18723 | 3.86e-07 | 5.65e-06 | 85 |
GO:003112312 | Thyroid | ATC | RNA 3'-end processing | 65/6293 | 116/18723 | 5.58e-07 | 7.93e-06 | 65 |
GO:00458414 | Thyroid | ATC | negative regulation of mitotic metaphase/anaphase transition | 29/6293 | 40/18723 | 5.62e-07 | 7.96e-06 | 29 |
GO:003112413 | Thyroid | ATC | mRNA 3'-end processing | 40/6293 | 62/18723 | 6.25e-07 | 8.65e-06 | 40 |
GO:004814432 | Thyroid | ATC | fibroblast proliferation | 49/6293 | 81/18723 | 6.38e-07 | 8.80e-06 | 49 |
GO:00330474 | Thyroid | ATC | regulation of mitotic sister chromatid segregation | 32/6293 | 46/18723 | 6.68e-07 | 9.13e-06 | 32 |
GO:005178411 | Thyroid | ATC | negative regulation of nuclear division | 37/6293 | 56/18723 | 6.82e-07 | 9.30e-06 | 37 |
GO:000708012 | Thyroid | ATC | mitotic metaphase plate congression | 34/6293 | 50/18723 | 6.95e-07 | 9.40e-06 | 34 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0411023 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa0411524 | Esophagus | ESCC | p53 signaling pathway | 65/4205 | 74/8465 | 3.88e-12 | 6.50e-11 | 3.33e-11 | 65 |
hsa0421829 | Esophagus | ESCC | Cellular senescence | 119/4205 | 156/8465 | 5.89e-12 | 9.40e-11 | 4.81e-11 | 119 |
hsa05170210 | Esophagus | ESCC | Human immunodeficiency virus 1 infection | 147/4205 | 212/8465 | 3.37e-09 | 3.53e-08 | 1.81e-08 | 147 |
hsa040689 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa041146 | Esophagus | ESCC | Oocyte meiosis | 77/4205 | 131/8465 | 2.19e-02 | 4.80e-02 | 2.46e-02 | 77 |
hsa0411033 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa0411534 | Esophagus | ESCC | p53 signaling pathway | 65/4205 | 74/8465 | 3.88e-12 | 6.50e-11 | 3.33e-11 | 65 |
hsa0421838 | Esophagus | ESCC | Cellular senescence | 119/4205 | 156/8465 | 5.89e-12 | 9.40e-11 | 4.81e-11 | 119 |
hsa0517038 | Esophagus | ESCC | Human immunodeficiency virus 1 infection | 147/4205 | 212/8465 | 3.37e-09 | 3.53e-08 | 1.81e-08 | 147 |
hsa0406814 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa0411411 | Esophagus | ESCC | Oocyte meiosis | 77/4205 | 131/8465 | 2.19e-02 | 4.80e-02 | 2.46e-02 | 77 |
hsa041102 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa0421822 | Liver | HCC | Cellular senescence | 102/4020 | 156/8465 | 4.18e-06 | 3.59e-05 | 2.00e-05 | 102 |
hsa040684 | Liver | HCC | FoxO signaling pathway | 85/4020 | 131/8465 | 3.99e-05 | 2.16e-04 | 1.20e-04 | 85 |
hsa051709 | Liver | HCC | Human immunodeficiency virus 1 infection | 125/4020 | 212/8465 | 4.51e-04 | 1.94e-03 | 1.08e-03 | 125 |
hsa041156 | Liver | HCC | p53 signaling pathway | 46/4020 | 74/8465 | 7.64e-03 | 2.08e-02 | 1.16e-02 | 46 |
hsa041103 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa0421832 | Liver | HCC | Cellular senescence | 102/4020 | 156/8465 | 4.18e-06 | 3.59e-05 | 2.00e-05 | 102 |
hsa040685 | Liver | HCC | FoxO signaling pathway | 85/4020 | 131/8465 | 3.99e-05 | 2.16e-04 | 1.20e-04 | 85 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CCNB1 | SNV | Missense_Mutation | c.893N>T | p.Gly298Val | p.G298V | P14635 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-E2-A15K-06 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
CCNB1 | insertion | Nonsense_Mutation | novel | c.1081_1082insTTCAATA | p.Trp361PhefsTer3 | p.W361Ffs*3 | P14635 | protein_coding | TCGA-A8-A07L-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | CR | |||
CCNB1 | insertion | Nonsense_Mutation | novel | c.454_455insTGTAGGTCCTTGGCTGGTCGGGC | p.Ala152ValfsTer2 | p.A152Vfs*2 | P14635 | protein_coding | TCGA-BH-A0HY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | taxotere | CR | ||
CCNB1 | SNV | Missense_Mutation | c.449N>C | p.Ile150Thr | p.I150T | P14635 | protein_coding | deleterious(0) | benign(0.003) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CCNB1 | SNV | Missense_Mutation | c.407C>T | p.Ala136Val | p.A136V | P14635 | protein_coding | tolerated(0.19) | benign(0.009) | TCGA-AA-A01K-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | folinic | CR | |
CCNB1 | SNV | Missense_Mutation | novel | c.1045N>G | p.Phe349Val | p.F349V | P14635 | protein_coding | tolerated(0.1) | benign(0.19) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CCNB1 | SNV | Missense_Mutation | c.785A>G | p.Tyr262Cys | p.Y262C | P14635 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
CCNB1 | SNV | Missense_Mutation | c.804N>G | p.Asp268Glu | p.D268E | P14635 | protein_coding | deleterious(0) | possibly_damaging(0.873) | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
CCNB1 | SNV | Missense_Mutation | c.815N>G | p.Val272Gly | p.V272G | P14635 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-D5-6928-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CCNB1 | SNV | Missense_Mutation | c.371C>G | p.Thr124Ser | p.T124S | P14635 | protein_coding | tolerated(0.72) | benign(0.001) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
891 | CCNB1 | DRUGGABLE GENOME | PROTOAPIGENONE | PROTOAPIGENONE | ||
891 | CCNB1 | DRUGGABLE GENOME | SELICICLIB | SELICICLIB | 21080703 | |
891 | CCNB1 | DRUGGABLE GENOME | KENPAULLONE | KENPAULLONE |
Page: 1 |